Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
6.67
-0.92 (-12.12%)
At close: Mar 31, 2025, 4:00 PM
6.51
-0.16 (-2.40%)
After-hours: Mar 31, 2025, 4:45 PM EDT
Rocket Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 163.64 | 55.9 | 140.52 | 232.69 | 297.1 | Upgrade
|
| Short-Term Investments | 208.7 | 317.27 | 215.88 | 156.05 | 185.62 | Upgrade
|
| Cash & Short-Term Investments | 372.34 | 373.18 | 356.39 | 388.74 | 482.72 | Upgrade
|
| Cash Growth | -0.22% | 4.71% | -8.32% | -19.47% | 58.73% | Upgrade
|
| Prepaid Expenses | 5.85 | 5.05 | 7.67 | 3.32 | 4.63 | Upgrade
|
| Total Current Assets | 378.18 | 378.22 | 364.06 | 392.06 | 487.35 | Upgrade
|
| Property, Plant & Equipment | 83.32 | 87.59 | 77.65 | 72.35 | 70.64 | Upgrade
|
| Long-Term Investments | - | 34.32 | 43.28 | - | - | Upgrade
|
| Goodwill | 39.15 | 39.15 | 39.15 | 30.82 | 30.82 | Upgrade
|
| Other Intangible Assets | 25.15 | 25.15 | 25.72 | - | - | Upgrade
|
| Other Long-Term Assets | 1.89 | 1.91 | 1.95 | 1.8 | 2.02 | Upgrade
|
| Total Assets | 527.7 | 566.34 | 551.81 | 497.02 | 590.82 | Upgrade
|
| Accounts Payable | 1.63 | 1.77 | 2.27 | 0.48 | 0.84 | Upgrade
|
| Accrued Expenses | 36.02 | 29.8 | 30.54 | 17.81 | 22.29 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | 4.88 | Upgrade
|
| Current Portion of Leases | 2.86 | 2.72 | 2.51 | 2.55 | 2.27 | Upgrade
|
| Current Unearned Revenue | - | - | 0.6 | 0.6 | 0.59 | Upgrade
|
| Other Current Liabilities | 0.19 | 14.21 | 3.25 | 0.73 | 1.76 | Upgrade
|
| Total Current Liabilities | 40.68 | 48.51 | 39.17 | 22.17 | 32.62 | Upgrade
|
| Long-Term Debt | - | - | - | - | 35.07 | Upgrade
|
| Long-Term Leases | 22.64 | 22.33 | 20.36 | 20.05 | 19.49 | Upgrade
|
| Other Long-Term Liabilities | 1.14 | 2.94 | 2.6 | 0.08 | 0.14 | Upgrade
|
| Total Liabilities | 64.47 | 73.77 | 62.12 | 42.3 | 87.31 | Upgrade
|
| Common Stock | 1.07 | 0.9 | 0.79 | 0.65 | 0.61 | Upgrade
|
| Additional Paid-In Capital | 1,680 | 1,451 | 1,203 | 946.15 | 825.79 | Upgrade
|
| Retained Earnings | -1,218 | -959.37 | -713.78 | -491.91 | -322.84 | Upgrade
|
| Treasury Stock | - | - | -0.05 | - | - | Upgrade
|
| Comprehensive Income & Other | 0.07 | 0.32 | -0.36 | -0.16 | -0.04 | Upgrade
|
| Total Common Equity | 463.23 | 492.57 | 489.69 | 454.72 | 503.52 | Upgrade
|
| Shareholders' Equity | 463.23 | 492.57 | 489.69 | 454.72 | 503.52 | Upgrade
|
| Total Liabilities & Equity | 527.7 | 566.34 | 551.81 | 497.02 | 590.82 | Upgrade
|
| Total Debt | 25.5 | 25.04 | 22.87 | 22.6 | 61.7 | Upgrade
|
| Net Cash (Debt) | 346.84 | 348.13 | 333.53 | 366.14 | 421.02 | Upgrade
|
| Net Cash Growth | -0.37% | 4.38% | -8.91% | -13.04% | 64.03% | Upgrade
|
| Net Cash Per Share | 3.66 | 4.14 | 4.89 | 5.79 | 7.60 | Upgrade
|
| Filing Date Shares Outstanding | 106.63 | 90.5 | 79.35 | 64.51 | 61.78 | Upgrade
|
| Total Common Shares Outstanding | 106.45 | 90.28 | 79.12 | 64.51 | 61 | Upgrade
|
| Working Capital | 337.5 | 329.72 | 324.89 | 369.89 | 454.73 | Upgrade
|
| Book Value Per Share | 4.35 | 5.46 | 6.19 | 7.05 | 8.25 | Upgrade
|
| Tangible Book Value | 398.93 | 428.27 | 424.81 | 423.91 | 472.7 | Upgrade
|
| Tangible Book Value Per Share | 3.75 | 4.74 | 5.37 | 6.57 | 7.75 | Upgrade
|
| Machinery | 48.85 | 44.58 | 35.61 | 25.21 | 19.84 | Upgrade
|
| Leasehold Improvements | 7.28 | 6.72 | 0.59 | 0.41 | 0.03 | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.